3/20
04:46 pm
tem
H.C. Wainwright Raises Tempus AI (TEM) Price Target to $95 [Yahoo! Finance]
Medium
Report
H.C. Wainwright Raises Tempus AI (TEM) Price Target to $95 [Yahoo! Finance]
3/17
08:30 am
tem
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries
Low
Report
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries
3/15
01:45 pm
tem
Cathie Wood buys $2 million of tumbling AI stock [Yahoo! Finance]
Low
Report
Cathie Wood buys $2 million of tumbling AI stock [Yahoo! Finance]
3/11
08:30 am
tem
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
Medium
Report
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
3/11
08:03 am
tem
Tempus AI (TEM) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $75.00 price target on the stock.
Medium
Report
Tempus AI (TEM) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $75.00 price target on the stock.
3/9
01:51 pm
tem
Tempus AI (TEM) had its price target raised by HC Wainwright from $89.00 to $95.00. They now have a "buy" rating on the stock.
Medium
Report
Tempus AI (TEM) had its price target raised by HC Wainwright from $89.00 to $95.00. They now have a "buy" rating on the stock.
3/7
07:22 am
tem
Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine [Yahoo! Finance]
Low
Report
Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine [Yahoo! Finance]
3/5
08:39 pm
tem
AI-Powered Tempus Inks New Multi-Year Merck Deal [Yahoo! Finance]
Low
Report
AI-Powered Tempus Inks New Multi-Year Merck Deal [Yahoo! Finance]
3/3
12:40 pm
tem
Tempus AI (TEM) had its price target lowered by Morgan Stanley from $85.00 to $70.00. They now have an "overweight" rating on the stock.
Low
Report
Tempus AI (TEM) had its price target lowered by Morgan Stanley from $85.00 to $70.00. They now have an "overweight" rating on the stock.
3/3
08:30 am
tem
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
Medium
Report
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
2/28
01:30 am
tem
Low
Report
2/26
08:30 am
tem
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
Medium
Report
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
2/25
04:43 pm
tem
Tempus AI: No AI Interruption Detected [Seeking Alpha]
Medium
Report
Tempus AI: No AI Interruption Detected [Seeking Alpha]
2/25
01:11 pm
tem
Tempus AI (TEM) was given a new $60.00 price target by Stifel Nicolaus.
Low
Report
Tempus AI (TEM) was given a new $60.00 price target by Stifel Nicolaus.
2/25
12:58 pm
tem
Tempus AI (TEM) had its price target lowered by JPMorgan Chase & Co. from $80.00 to $60.00. They now have a "neutral" rating on the stock.
Low
Report
Tempus AI (TEM) had its price target lowered by JPMorgan Chase & Co. from $80.00 to $60.00. They now have a "neutral" rating on the stock.
2/25
11:32 am
tem
Tempus AI (TEM) had its price target lowered by Needham & Company LLC from $100.00 to $75.00. They now have a "buy" rating on the stock.
Low
Report
Tempus AI (TEM) had its price target lowered by Needham & Company LLC from $100.00 to $75.00. They now have a "buy" rating on the stock.
2/25
08:03 am
tem
Tempus AI (TEM) had its price target lowered by BTIG Research from $105.00 to $90.00. They now have a "buy" rating on the stock.
Medium
Report
Tempus AI (TEM) had its price target lowered by BTIG Research from $105.00 to $90.00. They now have a "buy" rating on the stock.
2/25
12:27 am
tem
Tempus AI Inc (TEM) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and Strategic ... [Yahoo! Finance]
Medium
Report
Tempus AI Inc (TEM) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and Strategic ... [Yahoo! Finance]
2/24
04:01 pm
tem
Tempus Reports Fourth Quarter and Full Year 2025 Results
Low
Report
Tempus Reports Fourth Quarter and Full Year 2025 Results
2/20
07:28 am
tem
Tempus AI (NASDAQ:TEM) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Medium
Report
Tempus AI (NASDAQ:TEM) was upgraded by analysts at Mizuho to a "strong-buy" rating.
2/19
07:07 am
tem
Tempus AI (NASDAQ:TEM) was given a new $100.00 price target on by analysts at Mizuho.
Medium
Report
Tempus AI (NASDAQ:TEM) was given a new $100.00 price target on by analysts at Mizuho.
2/18
11:45 am
tem
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
Low
Report
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
2/18
08:30 am
tem
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
Medium
Report
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
2/18
06:58 am
tem
Tempus AI (NASDAQ:TEM) was upgraded by analysts at Robert W. Baird to a "strong-buy" rating.
Medium
Report
Tempus AI (NASDAQ:TEM) was upgraded by analysts at Robert W. Baird to a "strong-buy" rating.
2/17
07:17 am
tem
Tempus AI (NASDAQ:TEM) was given a new $59.00 price target on by analysts at Robert W. Baird.
Low
Report
Tempus AI (NASDAQ:TEM) was given a new $59.00 price target on by analysts at Robert W. Baird.